The Hidden Pattern: Why Long COVID Hits Hypermobile Bodies Harder

Can a single infection permanently change your health, or does it simply reveal something that was already there? In this episode, host Dr. Linda Bluestein, the Hypermobility MD, welcomes back Dr. Ina Stephens, Associate Director of the UVA Health EDS & Hypermobility Disorders Center, for an in-depth discussion about Long COVID, post-infectious syndromes, and their connection to Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), and immune dysfunction. Dr. Stephens explains why post-infectious illnesses are real and have been recognized for more than a century, tracing the pattern from the 1917 influenza pandemic and encephalitis lethargica to modern conditions including Long COVID, reactivated Epstein-Barr virus (EBV), Lyme disease, Babesia and other tick-borne infections, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). She shares the detective work behind her Diagnostic Dilemma Clinic, how a comprehensive history and targeted evaluation uncover hidden diagnoses, and why so many patients with complex chronic illness also have hypermobility. The conversation explores emerging research showing that people with hypermobility are approximately four times more likely to develop Long COVID, with an even greater risk in those with postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS). Dr. Stephens and Dr. Bluestein discuss the underlying biology, including immune dysregulation, autonomic nervous system dysfunction, vagus nerve dysfunction, mitochondrial dysfunction, and the ways connective tissue disorders may influence recovery after infection. They also review evidence-informed treatment strategies, including supporting mitochondrial health with coenzyme Q10 (CoQ10), glutathione, and N-acetylcysteine (NAC); the role of low-dose naltrexone (LDN); optimizing iron and vitamin C status; when antiviral medications may be appropriate; intravenous immunoglobulin (IVIG); and glucagon-like peptide-1 (GLP-1) receptor agonists. Finally, they explain why gradually increasing muscle mass and strength may have a greater long-term impact than any single supplement and share practical strategies for supporting recovery and strengthening your regimen at the first sign of illness. Takeaways: • Can a virus, Lyme disease, or another infection permanently change your health? • Why are people with Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD) so much more likely to develop Long COVID? • What do Long COVID, Lyme disease, ME/CFS, POTS, and other post-infectious conditions have in common? Go http://www.AquaTru.com now for 20% off (your purifier) using promo code BENDY. Want to learn more about the UVA EDS Center? For Appointments and Questions: [email protected] UVA EDS: https://www.uvahealth.com/healthy-pra... UVA EDS FAQ: https://www.uvahealth.com/support/eds... UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/speci... Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube:    / @bendybodiespodcast   Instagram: ⁠⁠⁠⁠  / ⁠⁠⁠⁠   Facebook: ⁠⁠⁠⁠  / bendybodiespodcast⁠⁠⁠⁠   X: ⁠⁠⁠⁠  / bluesteinlinda⁠⁠⁠⁠   LinkedIn: ⁠⁠⁠⁠  / ⁠⁠⁠⁠   Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobi... Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hyp... Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www\.bendybodiespodcast\.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www\.human-content\.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠[email protected]⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Chapters: 00:00 Microdosing for MCAS 00:35 Welcome and Episode Focus 01:47 Do Infections Trigger Chronic Illness 03:22 Proof of Post Infectious Syndromes 06:20 Inside the Diagnostic Dilemma Clinic 09:46 Workup Labs and Immune Clues 18:53 Long COVID Hypermobility and Mitochondria 44:52 Glutathione and EBV Support 46:22 Urolithin A and Mitophagy 49:31 Low Dose Naltrexone Explained 51:47 Experimental Antivirals and Biologics 59:35 NAD Infusions and Exercise Basics 01:08:36 Vitamin C Iron and Diet Gaps 01:12:49 Hypermobility Hacks and Wrap Up